Cosmos Health (NASDAQ:COSM) CEO Grigorios Siokas Buys 113,185 Shares

Posted by Patrick Bannon on Jan 14th, 2026

Cosmos Health Inc. (NASDAQ:COSM – Get Free Report) CEO Grigorios Siokas purchased 113,185 shares of the stock in a transaction dated Monday, January 12th. The stock was purchased at an average cost of $0.50 per share, for a total transaction of $56,592.50. Following the completion of the acquisition, the chief executive officer owned 7,244,979 shares of the company’s stock, valued at approximately $3,622,489.50. This represents a 1.59% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Grigorios Siokas also recently made the following trade(s):

On Thursday, January 8th, Grigorios Siokas bought 156,190 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.52 per share, for a total transaction of $81,218.80.
On Wednesday, January 7th, Grigorios Siokas purchased 124,880 shares of Cosmos Health stock. The stock was purchased at an average cost of $0.52 per share, with a total value of $64,937.60.
On Tuesday, January 6th, Grigorios Siokas purchased 133,953 shares of Cosmos Health stock. The shares were purchased at an average price of $0.54 per share, with a total value of $72,334.62.
On Friday, December 19th, Grigorios Siokas purchased 88,314 shares of Cosmos Health stock. The stock was purchased at an average cost of $0.49 per share, for a total transaction of $43,273.86.
On Monday, December 15th, Grigorios Siokas acquired 168,472 shares of Cosmos Health stock. The stock was acquired at an average price of $0.42 per share, for a total transaction of $70,758.24.
On Friday, November 28th, Grigorios Siokas acquired 76,360 shares of Cosmos Health stock. The shares were acquired at an average cost of $0.64 per share, with a total value of $48,870.40.
On Tuesday, November 25th, Grigorios Siokas bought 55,732 shares of Cosmos Health stock. The shares were acquired at an average price of $0.63 per share, with a total value of $35,111.16.
On Friday, November 21st, Grigorios Siokas bought 56,080 shares of Cosmos Health stock. The stock was acquired at an average price of $0.68 per share, for a total transaction of $38,134.40.
On Thursday, November 20th, Grigorios Siokas purchased 51,315 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.62 per share, for a total transaction of $31,815.30.
On Wednesday, November 19th, Grigorios Siokas purchased 61,614 shares of Cosmos Health stock. The shares were acquired at an average price of $0.65 per share, with a total value of $40,049.10.

Cosmos Health Stock Down 7.1%

Shares of NASDAQ COSM opened at $0.47 on Wednesday. The company has a current ratio of 0.99, a quick ratio of 0.84 and a debt-to-equity ratio of 0.25. The business has a 50-day moving average of $0.57 and a 200-day moving average of $0.73. The firm has a market capitalization of $17.50 million, a price-to-earnings ratio of -0.62 and a beta of 5.37. Cosmos Health Inc. has a 12 month low of $0.28 and a 12 month high of $1.32.

Cosmos Health (NASDAQ:COSM – Get Free Report) last announced its earnings results on Friday, November 14th. The company reported ($0.17) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.16). Cosmos Health had a negative net margin of 31.01% and a negative return on equity of 33.19%. The company had revenue of $17.11 million during the quarter, compared to analysts’ expectations of $16.40 million. Sell-side analysts expect that Cosmos Health Inc. will post -0.78 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Cosmos Health

A hedge fund recently raised its stake in Cosmos Health stock. Citadel Advisors LLC boosted its holdings in Cosmos Health Inc. (NASDAQ:COSM – Free Report) by 133.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 225,507 shares of the company’s stock after purchasing an additional 128,776 shares during the period. Citadel Advisors LLC owned approximately 0.65% of Cosmos Health worth $250,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 12.61% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently issued reports on the stock. Weiss Ratings reiterated a “sell (d-)” rating on shares of Cosmos Health in a research report on Wednesday, October 8th. Wall Street Zen raised Cosmos Health to a “hold” rating in a research note on Saturday, September 20th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company currently has an average rating of “Sell”.

View Our Latest Stock Report on COSM

Cosmos Health Company Profile

(Get Free Report)

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.